FI92210B - Förfarande för framställning av farmaceutiskt användbara GRF-analoger - Google Patents
Förfarande för framställning av farmaceutiskt användbara GRF-analoger Download PDFInfo
- Publication number
- FI92210B FI92210B FI851842A FI851842A FI92210B FI 92210 B FI92210 B FI 92210B FI 851842 A FI851842 A FI 851842A FI 851842 A FI851842 A FI 851842A FI 92210 B FI92210 B FI 92210B
- Authority
- FI
- Finland
- Prior art keywords
- arg
- leu
- ser
- ala
- ile
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth-hormone releasing factors (GH-RF) (Somatoliberin)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
Claims (6)
1. Förfarande för framställning av farmaceutiskt användbara syntetiska peptidanaloger av tillväxthormon 5 frigörande faktor med sekvensen: Rl-R2-Asp-Ala-Ile-Phe-Thr-R8-Ser-R10-Arg-R12-R13-R14-Gly-Gln-Leu-R18-Ala-Arg-Lys-Leu-Leu-R24-R25-Ile-Nle-R28-R2g -NHR, där Rx är Tyr eller His; R2 är Ala eller D-NMA; R8 är Ser eller Asn; R10 är Tyr eller D-Tyr; R12 är Arg eller Lys; R13 är Ile 10 eller Vai; R14 är Leu eller D-Leu; R18 är Tyr eller Ser; R24 är His eller Gin; R25 är Glu eller Asp; R28 är Asn eller Ser; R29 är Arg eller D-Arg; och R är H eller CH2CH3; förut-satt dock, att R29 eller R28 - R29 kan lämnas bort, och för-utsatt ocksä, att R2 är D-NMA och/eller R14 är D-Leu och/ 15 eller R29 är D-Arg, kännetecknat därav, att man (a) bildar en peptidmellanprodukt med ätminstone en skyddsgrupp och med formeln (II) eller en ändamälsenligt förkortad version därav: X1-R1(X eller X2)-R2-Asp(X3)-Ala-Ile-Phe-Thr (X4) -R8( X4 eller X5)-Ser(X4)-R10(X2)-Arg(X6)-R12(X6 20 eller X7 ) -R13-R14-Gly-Gln( X5) -Leu-R18( X2 eller X4) -Ala-Arg( X6) - Lys(X7)-Leu-Leu-R24(X eller X5)-R25(X3)-Ile-Nle-R28(X4 eller X5)-R29(X6)-X9 där: X, X1, X2, X3, X4, X5, X6 och X7 var för sig är antingen väte eller en skyddsgrupp och X9 är anting-en en skyddsgrupp eller en förankringsbindning vid harts-' 25 bäraren eller är des-X9, i vilket fall C-terminalen är NHR, (b) spjälker skyddsgruppen eller -grupperna eller förankringsbindningen ur peptiden med formeln (II); och renar den erhällna peptiden.
2. Förfarande enligt patentkravet 1, k ä n n e -30 tecknat därav, att R2 är D-NMA.
3. Förfarande enligt patentkravet 1 eller 2, kännetecknat därav, att R29 är D-Arg.
4. Förfarande enligt nägot av patentkraven 1-3, kännetecknat därav, att R14 är D-Leu. II 92210 25
5. Förfarande enligt patentkravet 1, kanne-t e c k n a t därav, att Rj är D-NMA och och R2e är Asn.
6. Förfarande enligt patentkravet 1, kanne- t e c k n a t därav, att man framställer en syntetisk 5 peptid med formeln: H-Tyr-D-NMA-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-Ser-Arg-NH2.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61184484 | 1984-05-18 | ||
US06/611,844 US4528190A (en) | 1983-10-25 | 1984-05-18 | GRF Analogs IV |
Publications (4)
Publication Number | Publication Date |
---|---|
FI851842A0 FI851842A0 (sv) | 1985-05-09 |
FI851842L FI851842L (sv) | 1985-11-19 |
FI92210B true FI92210B (sv) | 1994-06-30 |
FI92210C FI92210C (sv) | 1994-10-10 |
Family
ID=24450622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI851842A FI92210C (sv) | 1984-05-18 | 1985-05-09 | Förfarande för framställning av farmaceutiskt användbara GRF-analoger |
Country Status (25)
Country | Link |
---|---|
US (1) | US4528190A (sv) |
EP (1) | EP0161852B1 (sv) |
JP (1) | JPH0689036B2 (sv) |
KR (1) | KR910000379B1 (sv) |
AT (1) | ATE73823T1 (sv) |
AU (1) | AU578467B2 (sv) |
CA (1) | CA1271299A (sv) |
DD (1) | DD236536A5 (sv) |
DE (1) | DE3585634D1 (sv) |
DK (1) | DK162103C (sv) |
EG (1) | EG17394A (sv) |
ES (1) | ES8606412A1 (sv) |
FI (1) | FI92210C (sv) |
GR (1) | GR851207B (sv) |
HU (1) | HU197759B (sv) |
IE (1) | IE57813B1 (sv) |
IL (1) | IL75088A (sv) |
MX (1) | MX157381A (sv) |
NO (1) | NO168043C (sv) |
NZ (1) | NZ212113A (sv) |
PH (1) | PH20976A (sv) |
PT (1) | PT80450B (sv) |
SU (1) | SU1530097A3 (sv) |
YU (1) | YU46153B (sv) |
ZA (1) | ZA852919B (sv) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4728726A (en) * | 1982-10-04 | 1988-03-01 | The Salk Institute For Biological Studies | GRF analogs IIIb |
US4732972A (en) * | 1983-03-07 | 1988-03-22 | Hoffmann-La Roche Inc. | Polypeptides having growth hormone releasing activity |
US4649131A (en) * | 1984-09-24 | 1987-03-10 | Hoffmann-La Roche Inc. | Growth hormone releasing factor analogs |
CA1271600A (en) * | 1985-01-07 | 1990-07-10 | David Howard Coy | Growth hormone-releasing peptides and method of treating mammals therewith |
EP0193910A3 (en) * | 1985-03-06 | 1988-11-23 | Sumitomo Pharmaceuticals Company, Limited | Synthesis of a derivative of grf and intermediate peptides |
US4734399A (en) * | 1985-08-06 | 1988-03-29 | Hoffmann-La Roche Inc. | Growth hormone releasing factor analogs |
US4689318A (en) * | 1985-08-29 | 1987-08-25 | The Salk Institute For Biological Studies | GRF analogs |
US4880778A (en) * | 1986-05-12 | 1989-11-14 | Eastman Kodak Company | Combinations having synergistic growth hormone releasing activity and methods for use thereof |
FR2599038B1 (fr) * | 1986-05-26 | 1990-06-29 | Sanofi Sa | Procede de preparation de nonacosapeptides et peptides intermediaires |
DE3742633A1 (de) * | 1987-12-16 | 1989-06-29 | Hoechst Ag | Peptide mit beeinflussender wirkung auf die hypophyse von saeugern |
US5565606A (en) * | 1986-10-21 | 1996-10-15 | Hoechst Aktiengesellschaft | Synthesis of peptide aminoalkylamides and peptide hydrazides by the solid-phase method |
US4843064A (en) * | 1987-01-13 | 1989-06-27 | The Salk Institute For Biological Studies | GRF analogs V |
IL84758A (en) * | 1987-01-13 | 1992-03-29 | Salk Inst For Biological Studi | Peptides stimulating the release of pituitary growth hormone in fish and amphibians,and pharmaceutical compositions containing them |
US4914189A (en) * | 1987-02-05 | 1990-04-03 | The Adminstrators Of The Tulane Educational Fund | Synthetic GHRH analogs |
EP0289186A3 (en) * | 1987-04-23 | 1990-04-04 | International Minerals And Chemical Corporation | Process for increasing the growth rate and enhancing the feed efficiency of meat producing livestock |
IL86102A (en) * | 1987-05-11 | 1994-04-12 | Univ Tulane | Alkylated peptides that release growth hormone and their use |
US5112808A (en) * | 1987-05-11 | 1992-05-12 | American Cyanamid Company | Alkylated hormone-releasing peptides and method of treatig mammals therewith |
US5002931A (en) * | 1987-05-22 | 1991-03-26 | The Salk Institute For Biological Studies | GRF analogs VII |
US4839344A (en) * | 1987-06-12 | 1989-06-13 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
US4801456A (en) * | 1987-07-09 | 1989-01-31 | International Minerals & Chemical Corp. | Growth hormone-releasing factor analogs |
USRE33699E (en) * | 1987-07-09 | 1991-09-24 | International Minerals & Chemical Corp. | Growth hormone-releasing factor analogs |
US4880777A (en) * | 1987-09-01 | 1989-11-14 | Eastman Kodak Company | Synthetic peptides having growth hormone releasing activity |
ES2054754T3 (es) * | 1987-09-18 | 1994-08-16 | Hoffmann La Roche | Analogos ciclicos del grf. |
WO1989007110A1 (en) * | 1988-01-28 | 1989-08-10 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
US5043322A (en) * | 1988-07-22 | 1991-08-27 | The Salk Institute For Biological Studies | Cyclic GRF analogs |
US5023322A (en) * | 1988-08-31 | 1991-06-11 | Mta Kutatas-Es Szervezetelemzo Intezete | Analogs of growth hormone releasing factor (GRF) and a method for the preparation thereof |
US5756458A (en) * | 1989-06-16 | 1998-05-26 | Pharmacia & Upjohn Company | Stabilized potent GRF analogs |
US5716937A (en) * | 1989-12-13 | 1998-02-10 | The General Hospital Corporation | Method for treating cardiac malfunction |
JPH06500311A (ja) * | 1990-06-29 | 1994-01-13 | エフ・ホフマン―ラ ロシュ アーゲー | ヒスチジン置換されたヒト成長ホルモン放出因子類縁体 |
ATE119916T1 (de) * | 1990-12-10 | 1995-04-15 | Hoffmann La Roche | Verfahren zur enzymatischen herstellung von grf(1-44)nh2. |
JPH05507939A (ja) * | 1991-04-09 | 1993-11-11 | エフ・ホフマン―ラ ロシユ アーゲー | 成長ホルモン放出因子の類似体 |
ZA922746B (en) * | 1991-04-26 | 1992-12-30 | Lilly Co Eli | Superactive grf analogs |
US5246920A (en) * | 1992-06-15 | 1993-09-21 | University Of South Florida | Treatment of hyperprolactinemia |
US5811074A (en) * | 1992-06-29 | 1998-09-22 | University Of South Florida | Method of diagnosing pituitary dependent growth hormone deficiency |
GB9324691D0 (en) * | 1993-12-01 | 1994-01-19 | Hafslund Nycomed As | Peptide compounds |
US5550212A (en) * | 1993-12-17 | 1996-08-27 | The Administrators Of The Tulane Educational Fund | Analogues of hGH-RH(1-29)NH2 having antagonistic activity |
IT1285405B1 (it) * | 1995-06-06 | 1998-06-03 | Alza Corp | Modificazione di farmaci polipeptidici per accrescere il flusso per elettrotrasporto. |
AU2002233082B2 (en) * | 2001-02-02 | 2005-11-10 | Conjuchem Biotechnologies Inc. | Long lasting growth hormone releasing factor derivatives |
NZ539218A (en) * | 2002-09-18 | 2008-03-28 | Univ Montreal Ct Hospitalier Chum | Synthetic GHRH analogues of 29 amino acids or more |
WO2009009727A2 (en) * | 2007-07-12 | 2009-01-15 | Akela Pharma Srl | Ghrh analogs and therapeutic uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4563352A (en) * | 1982-10-04 | 1986-01-07 | The Salk Institute For Biological Studies | Human pancreatic GRF |
US4518586A (en) * | 1983-01-13 | 1985-05-21 | The Salk Institute For Biological Studies | GRF Analogs III |
IL70530A (en) * | 1983-01-13 | 1986-09-30 | Salk Inst For Biological Studi | Synthetic peptides having growth hormone releasing factor activity and compositions containing them |
AU575843B2 (en) * | 1983-08-10 | 1988-08-11 | The Administrators Of The Tulane Eductional Fund | Growth hormone releasing peptides |
-
1984
- 1984-05-18 US US06/611,844 patent/US4528190A/en not_active Expired - Lifetime
-
1985
- 1985-04-18 ZA ZA852919A patent/ZA852919B/xx unknown
- 1985-04-26 DE DE8585302975T patent/DE3585634D1/de not_active Expired - Fee Related
- 1985-04-26 AT AT85302975T patent/ATE73823T1/de not_active IP Right Cessation
- 1985-04-26 EP EP85302975A patent/EP0161852B1/en not_active Expired - Lifetime
- 1985-04-29 IE IE1087/85A patent/IE57813B1/en not_active IP Right Cessation
- 1985-05-02 CA CA000480584A patent/CA1271299A/en not_active Expired - Fee Related
- 1985-05-03 IL IL75088A patent/IL75088A/xx not_active IP Right Cessation
- 1985-05-08 PH PH32242A patent/PH20976A/en unknown
- 1985-05-09 FI FI851842A patent/FI92210C/sv not_active IP Right Cessation
- 1985-05-10 YU YU77185A patent/YU46153B/sh unknown
- 1985-05-13 PT PT80450A patent/PT80450B/pt not_active IP Right Cessation
- 1985-05-15 AU AU42488/85A patent/AU578467B2/en not_active Ceased
- 1985-05-15 NO NO851947A patent/NO168043C/no not_active IP Right Cessation
- 1985-05-16 EG EG306/85A patent/EG17394A/xx active
- 1985-05-17 DD DD85276457A patent/DD236536A5/de not_active IP Right Cessation
- 1985-05-17 MX MX105337A patent/MX157381A/es unknown
- 1985-05-17 NZ NZ212113A patent/NZ212113A/en unknown
- 1985-05-17 HU HU851870A patent/HU197759B/hu not_active IP Right Cessation
- 1985-05-17 GR GR851207A patent/GR851207B/el unknown
- 1985-05-17 SU SU853898058A patent/SU1530097A3/ru active
- 1985-05-17 DK DK220685A patent/DK162103C/da not_active IP Right Cessation
- 1985-05-17 ES ES543235A patent/ES8606412A1/es not_active Expired
- 1985-05-17 JP JP60105746A patent/JPH0689036B2/ja not_active Expired - Fee Related
- 1985-05-17 KR KR1019850003400A patent/KR910000379B1/ko not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI92210B (sv) | Förfarande för framställning av farmaceutiskt användbara GRF-analoger | |
FI88402C (sv) | Förfarande för framställning av terapeutiskt användbara GRF-analoger | |
CA1243016A (en) | Human grf peptide analogs | |
US4529595A (en) | GRF Analogs | |
US4626523A (en) | GRF analogs II | |
FI87080B (fi) | Foerfarande foer framstaellning av grf -analoger. | |
KR0138907B1 (ko) | 합성 펩티드 | |
US4595676A (en) | Rat hypothalamic GRF | |
US5262519A (en) | GRF analogs XI | |
US4628043A (en) | Hypothalamic GRF agonists | |
US4728726A (en) | GRF analogs IIIb | |
FI89499C (sv) | Förfarande för framställning av terapeutiskt användbar peptid | |
US5098995A (en) | GRF Analogs VIIA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
MM | Patent lapsed |
Owner name: THE SALK INSTITUTE FOR BIOLOGICAL |